Business Description
JBM (Healthcare) Ltd
ISIN : KYG1090B1077
Share Class Description:
HKSE:02161: Ordinary SharesTotal Employee Number:
412Compare
Compare
Traded in other countries / regions
02161.Hong Kong IPO Date
2021-02-05Description
JBM (Healthcare) Ltd markets and distributes healthcare products. The company's operating segment includes Branded medicines; Proprietary Chinese medicines and Health and wellness products. It generates maximum revenue from the Proprietary Chinese medicines segment. The Proprietary Chinese medicines segment develops, manufactures, and distributes registered Chinese medicines composed solely of any Chinese herbal medicines specified in the Chinese Medicine Ordinance, or any materials of herbal, animal, or mineral origin customarily or widely used by the Chinese. Geographically, it derives a majority of its revenue from Hong Kong.
Financial Strength
6/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Cash-To-Debt | 0.31 | |||||
Equity-to-Asset | 0.61 | |||||
Debt-to-Equity | 0.37 | |||||
Debt-to-EBITDA | 1.49 | |||||
Interest Coverage | 21.85 | |||||
Piotroski F-Score | 5/9 | |||||
Altman Z-Score | 3.03 | |||||
Beneish M-Score | -1.93 | |||||
WACC vs ROIC | ||||||
Growth Rank
10/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
3-Year Revenue Growth Rate | 20.5 | |||||
3-Year EBITDA Growth Rate | 38.7 | |||||
3-Year EPS without NRI Growth Rate | 64 | |||||
3-Year FCF Growth Rate | 0.9 | |||||
3-Year Book Growth Rate | 6.7 | |||||
Future 3-5Y EPS without NRI Growth Rate Estimate Industry Rank | 6.95 | |||||
Future 3-5Y Total Revenue Growth Rate Estimate | 5.58 |
Momentum Rank
3/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
5-Day RSI | 41.12 | |||||
9-Day RSI | 39.99 | |||||
14-Day RSI | 39.46 | |||||
3-1 Month Momentum % | -20.24 | |||||
6-1 Month Momentum % | -25.66 | |||||
12-1 Month Momentum % | -34.11 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Current Ratio | 1.9 | |||||
Quick Ratio | 1.59 | |||||
Cash Ratio | 0.47 | |||||
Days Inventory | 83.9 | |||||
Days Sales Outstanding | 83.09 | |||||
Days Payable | 21.56 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Dividend Yield % | 10.95 | |||||
Dividend Payout Ratio | 0.86 | |||||
3-Year Dividend Growth Rate | 249.3 | |||||
Forward Dividend Yield % | 7.58 | |||||
5-Year Yield-on-Cost % | 10.95 | |||||
3-Year Average Share Buyback Ratio | 3.4 | |||||
Shareholder Yield % | -4.94 |
Profitability Rank
8/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Gross Margin % | 55.78 | |||||
Operating Margin % | 30.59 | |||||
Net Margin % | 24.09 | |||||
EBITDA Margin % | 31.61 | |||||
FCF Margin % | 15.47 | |||||
OCF Margin % | 19.46 | |||||
ROE % | 18.66 | |||||
ROA % | 11.88 | |||||
ROIC % | 15.15 | |||||
3-Year ROIIC % | 43.71 | |||||
ROC (Joel Greenblatt) % | 71.21 | |||||
ROCE % | 18.18 | |||||
Years of Profitability over Past 10-Year | 9 |
GF Value Rank
7/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
PE Ratio | 7.89 | |||||
Forward PE Ratio | 7.38 | |||||
PE Ratio without NRI | 7.85 | |||||
Price-to-Owner-Earnings | 13.76 | |||||
PEG Ratio | 0.22 | |||||
PS Ratio | 1.9 | |||||
PB Ratio | 1.47 | |||||
Price-to-Tangible-Book | 38.8 | |||||
Price-to-Free-Cash-Flow | 12.28 | |||||
Price-to-Operating-Cash-Flow | 9.75 | |||||
EV-to-EBIT | 7.18 | |||||
EV-to-EBITDA | 7.18 | |||||
EV-to-Revenue | 2.27 | |||||
EV-to-FCF | 14.67 | |||||
Price-to-GF-Value | 0.93 | |||||
Price-to-Projected-FCF | 0.63 | |||||
Price-to-Peter-Lynch-Fair-Value | 0.31 | |||||
Price-to-Graham-Number | 3.88 | |||||
Earnings Yield (Greenblatt) % | 13.93 | |||||
FCF Yield % | 8.14 | |||||
Forward Rate of Return (Yacktman) % | 27.41 |
Operating Revenue by Business Segment
Operating Revenue by Geographic Region
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
JBM (Healthcare) Ltd Executives
DetailsAnalyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil HK$) | 834.634 | ||
| EPS (TTM) (HK$) | 0.246 | ||
| Beta | -0.0865 | ||
| 3-Year Sharpe Ratio | 0.4 | ||
| 3-Year Sortino Ratio | 1.27 | ||
| Volatility % | 19.82 | ||
| 14-Day RSI | 39.46 | ||
| 14-Day ATR (HK$) | 0.0467 | ||
| 20-Day SMA (HK$) | 1.985 | ||
| 12-1 Month Momentum % | -34.11 | ||
| 52-Week Range (HK$) | 1.84 - 3.19 | ||
| Shares Outstanding (Mil) | 817.6 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 5 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
JBM (Healthcare) Ltd Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
JBM (Healthcare) Ltd Stock Events
| Event | Date | Price (HK$) | ||
|---|---|---|---|---|
| HKD 0.073500 Cash Dividend | 2026-09-07 | In 34 days | ||
| HKD 0.097500 Cash Dividend | 2025-11-28 | 3.00 (-0.66%) | ||
| HKD 0.115000 Cash Dividend | 2025-08-11 | 3.07 (-0.32%) | ||
| HKD 0.055000 Cash Dividend | 2024-12-17 | 1.92 (-0.52%) | ||
| HKD 0.040500 Cash Dividend | 2024-08-15 | 0.95 (-1.04%) |
Show
Entries
JBM (Healthcare) Ltd Frequently Asked Questions
What is JBM (Healthcare) Ltd(HKSE:02161)'s stock price today?
The current price of HKSE:02161 is HK$1.94. The 52 week high of HKSE:02161 is HK$3.19 and 52 week low is HK$1.84.
When is next earnings date of JBM (Healthcare) Ltd(HKSE:02161)?
The next earnings date of JBM (Healthcare) Ltd(HKSE:02161) is .
Does JBM (Healthcare) Ltd(HKSE:02161) pay dividends? If so, how much?
The Dividend Yield %  of JBM (Healthcare) Ltd(HKSE:02161) is 10.95% (As of Today), Highest Dividend Payout Ratio of JBM (Healthcare) Ltd(HKSE:02161) was 0.86. The lowest was 0.09. And the median was 0.41. The  Forward Dividend Yield % of JBM (Healthcare) Ltd(HKSE:02161) is 7.58%. For more information regarding to dividend, please check our Dividend Page.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Articles on JBM (Healthcare) Ltd
No articles.
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers